Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Amortizatization of Intangibles (2021 - 2025)

Pliant Therapeutics (PLRX) has disclosed Amortizatization of Intangibles for 5 consecutive years, with $828000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Amortizatization of Intangibles rose 2.1% to $828000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $3.3 million, a 5.04% decrease, with the full-year FY2025 number at $3.3 million, down 5.04% from a year prior.
  • Amortizatization of Intangibles was $828000.0 for Q4 2025 at Pliant Therapeutics, up from $821000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $2.6 million in Q1 2023 to a low of -$1.3 million in Q2 2023.
  • A 5-year average of $632250.0 and a median of $639500.0 in 2022 define the central range for Amortizatization of Intangibles.
  • Biggest YoY gain for Amortizatization of Intangibles was 959.02% in 2023; the steepest drop was 406.36% in 2023.
  • Pliant Therapeutics' Amortizatization of Intangibles stood at $806000.0 in 2021, then dropped by 25.81% to $598000.0 in 2022, then fell by 6.86% to $557000.0 in 2023, then skyrocketed by 45.6% to $811000.0 in 2024, then rose by 2.1% to $828000.0 in 2025.
  • Per Business Quant, the three most recent readings for PLRX's Amortizatization of Intangibles are $828000.0 (Q4 2025), $821000.0 (Q3 2025), and $815000.0 (Q2 2025).